- IBDEI3B3 ; ; 04-FEB-2020
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- Q:'DIFQR(358.4) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.4,639,0)
- ;;=ED OBS (ADMIT&D/C SAME DAY)^2^71
- ;;^UTILITY(U,$J,358.4,640,0)
- ;;=ED COMMON DIAGNOSES^1^72
- ;;^UTILITY(U,$J,358.4,641,0)
- ;;=ADMINISTRATIVE TOPICS^2^72
- ;;^UTILITY(U,$J,358.4,642,0)
- ;;=CARDIOVASCULAR^3^72
- ;;^UTILITY(U,$J,358.4,643,0)
- ;;=EAR/NOSE/THROAT^6^72
- ;;^UTILITY(U,$J,358.4,644,0)
- ;;=ENDO/RENAL/ELECTROLYTES^5^72
- ;;^UTILITY(U,$J,358.4,645,0)
- ;;=EYE^7^72
- ;;^UTILITY(U,$J,358.4,646,0)
- ;;=GI/ABDOMEN^8^72
- ;;^UTILITY(U,$J,358.4,647,0)
- ;;=PSYCHIATRY^17^72
- ;;^UTILITY(U,$J,358.4,648,0)
- ;;=PAIN/LACERATION/WOUNDS^16^72
- ;;^UTILITY(U,$J,358.4,649,0)
- ;;=PULMONARY^18^72
- ;;^UTILITY(U,$J,358.4,650,0)
- ;;=GU/RECTAL^9^72
- ;;^UTILITY(U,$J,358.4,651,0)
- ;;=HEME/ONC/VASCULAR^10^72
- ;;^UTILITY(U,$J,358.4,652,0)
- ;;=INFECTIOUS DISEASE^11^72
- ;;^UTILITY(U,$J,358.4,653,0)
- ;;=MUSCULOSKELETAL/MISC^14^72
- ;;^UTILITY(U,$J,358.4,654,0)
- ;;=NEUROLOGY^15^72
- ;;^UTILITY(U,$J,358.4,655,0)
- ;;=SKIN^19^72
- ;;^UTILITY(U,$J,358.4,656,0)
- ;;=MUSCULOSKELETAL-LE^12^72
- ;;^UTILITY(U,$J,358.4,657,0)
- ;;=MUSCULOSKELETAL-UE^13^72
- ;;^UTILITY(U,$J,358.4,658,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^20^72
- ;;^UTILITY(U,$J,358.4,659,0)
- ;;=E-CIG/VAPE LUNG INJURY (EVAL)^4^72
- ;;^UTILITY(U,$J,358.4,660,0)
- ;;=MISC-FALLS^21^72
- ;;^UTILITY(U,$J,358.4,661,0)
- ;;=MISC-VEHICLE ACCIDENTS^22^72
- ;;^UTILITY(U,$J,358.4,662,0)
- ;;=MISC-BITES,PUNCTURE WOUNDS,ASSAULTS^23^72
- ;;^UTILITY(U,$J,358.4,663,0)
- ;;=TEST - CATARACT / COLOR^4^73
- ;;^UTILITY(U,$J,358.4,664,0)
- ;;=IMAGING / PHOTOS^2^73
- ;;^UTILITY(U,$J,358.4,665,0)
- ;;=TEST - GLAUCOMA^3^73
- ;;^UTILITY(U,$J,358.4,666,0)
- ;;=TEST - OTHER^5^73
- ;;^UTILITY(U,$J,358.4,667,0)
- ;;=REFRACT / GLASSES / CL^1^73
- ;;^UTILITY(U,$J,358.4,668,0)
- ;;=EEF Version 2020 February^6^73
- ;;^UTILITY(U,$J,358.4,669,0)
- ;;=LOW VISION / BLINDNESS^21^74
- ;;^UTILITY(U,$J,358.4,670,0)
- ;;=RETINA - VASCULAR^12^74
- ;;^UTILITY(U,$J,358.4,671,0)
- ;;=EYELIDS / LASHES^2^74
- ;;^UTILITY(U,$J,358.4,672,0)
- ;;=NEURO / STRABISMUS^18^74
- ;;^UTILITY(U,$J,358.4,673,0)
- ;;=ORBIT - PLASTICS^20^74
- ;;^UTILITY(U,$J,358.4,674,0)
- ;;=VITREOUS^17^74
- ;;^UTILITY(U,$J,358.4,675,0)
- ;;=ORBIT - TRAUMA^19^74
- ;;^UTILITY(U,$J,358.4,676,0)
- ;;=LACRIMAL / NLD / NEOPLASMS^3^74
- ;;^UTILITY(U,$J,358.4,677,0)
- ;;=MOST FREQUENT^1^74
- ;;^UTILITY(U,$J,358.4,678,0)
- ;;=CONJUNCTIVA / SCLERA^4^74
- ;;^UTILITY(U,$J,358.4,679,0)
- ;;=CORNEA / ULCER^5^74
- ;;^UTILITY(U,$J,358.4,680,0)
- ;;=LENS / CATARACT / POSTOP^6^74
- ;;^UTILITY(U,$J,358.4,681,0)
- ;;=IRIS / UVEITIS^7^74
- ;;^UTILITY(U,$J,358.4,682,0)
- ;;=GLAUCOMA - OPEN ANGLE^8^74
- ;;^UTILITY(U,$J,358.4,683,0)
- ;;=GLAUCOMA - CLOSED ANGLE^9^74
- ;;^UTILITY(U,$J,358.4,684,0)
- ;;=GLAUCOMA - SECONDARY^10^74
- ;;^UTILITY(U,$J,358.4,685,0)
- ;;=RETINA - CHOROID / TUMORS / INFLAM^14^74
- ;;^UTILITY(U,$J,358.4,686,0)
- ;;=RETINA - TEAR / PERIPH / DEGENERATION^15^74
- ;;^UTILITY(U,$J,358.4,687,0)
- ;;=RETINA - MACULA^11^74
- ;;^UTILITY(U,$J,358.4,688,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^23^74
- ;;^UTILITY(U,$J,358.4,689,0)
- ;;=PMH / OTHER^22^74
- ;;^UTILITY(U,$J,358.4,690,0)
- ;;=RETINA - VEGF INJECT DX CODES^16^74
- ;;^UTILITY(U,$J,358.4,691,0)
- ;;=RETINA - DIABETIC RETINOPATHY^13^74
- ;;^UTILITY(U,$J,358.4,692,0)
- ;;=NEW PATIENT^3^75
- ;;^UTILITY(U,$J,358.4,693,0)
- ;;=ESTABLISHED PATIENT^2^75
- ;;^UTILITY(U,$J,358.4,694,0)
- ;;=CONSULTS - OUTPT^4^75
- ;;^UTILITY(U,$J,358.4,695,0)
- ;;=EYE CODES^1^75
- ;;^UTILITY(U,$J,358.4,696,0)
- ;;=CONSULTS - INPT^5^75
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3B3 3778 printed Jan 18, 2025@03:46:30 Page 2
- IBDEI3B3 ; ; 04-FEB-2020
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
- +2 if 'DIFQR(358.4)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.4,639,0)
- +2 ;;=ED OBS (ADMIT&D/C SAME DAY)^2^71
- +3 ;;^UTILITY(U,$J,358.4,640,0)
- +4 ;;=ED COMMON DIAGNOSES^1^72
- +5 ;;^UTILITY(U,$J,358.4,641,0)
- +6 ;;=ADMINISTRATIVE TOPICS^2^72
- +7 ;;^UTILITY(U,$J,358.4,642,0)
- +8 ;;=CARDIOVASCULAR^3^72
- +9 ;;^UTILITY(U,$J,358.4,643,0)
- +10 ;;=EAR/NOSE/THROAT^6^72
- +11 ;;^UTILITY(U,$J,358.4,644,0)
- +12 ;;=ENDO/RENAL/ELECTROLYTES^5^72
- +13 ;;^UTILITY(U,$J,358.4,645,0)
- +14 ;;=EYE^7^72
- +15 ;;^UTILITY(U,$J,358.4,646,0)
- +16 ;;=GI/ABDOMEN^8^72
- +17 ;;^UTILITY(U,$J,358.4,647,0)
- +18 ;;=PSYCHIATRY^17^72
- +19 ;;^UTILITY(U,$J,358.4,648,0)
- +20 ;;=PAIN/LACERATION/WOUNDS^16^72
- +21 ;;^UTILITY(U,$J,358.4,649,0)
- +22 ;;=PULMONARY^18^72
- +23 ;;^UTILITY(U,$J,358.4,650,0)
- +24 ;;=GU/RECTAL^9^72
- +25 ;;^UTILITY(U,$J,358.4,651,0)
- +26 ;;=HEME/ONC/VASCULAR^10^72
- +27 ;;^UTILITY(U,$J,358.4,652,0)
- +28 ;;=INFECTIOUS DISEASE^11^72
- +29 ;;^UTILITY(U,$J,358.4,653,0)
- +30 ;;=MUSCULOSKELETAL/MISC^14^72
- +31 ;;^UTILITY(U,$J,358.4,654,0)
- +32 ;;=NEUROLOGY^15^72
- +33 ;;^UTILITY(U,$J,358.4,655,0)
- +34 ;;=SKIN^19^72
- +35 ;;^UTILITY(U,$J,358.4,656,0)
- +36 ;;=MUSCULOSKELETAL-LE^12^72
- +37 ;;^UTILITY(U,$J,358.4,657,0)
- +38 ;;=MUSCULOSKELETAL-UE^13^72
- +39 ;;^UTILITY(U,$J,358.4,658,0)
- +40 ;;=SUICIDE IDEATIONS/ATTEMPTS^20^72
- +41 ;;^UTILITY(U,$J,358.4,659,0)
- +42 ;;=E-CIG/VAPE LUNG INJURY (EVAL)^4^72
- +43 ;;^UTILITY(U,$J,358.4,660,0)
- +44 ;;=MISC-FALLS^21^72
- +45 ;;^UTILITY(U,$J,358.4,661,0)
- +46 ;;=MISC-VEHICLE ACCIDENTS^22^72
- +47 ;;^UTILITY(U,$J,358.4,662,0)
- +48 ;;=MISC-BITES,PUNCTURE WOUNDS,ASSAULTS^23^72
- +49 ;;^UTILITY(U,$J,358.4,663,0)
- +50 ;;=TEST - CATARACT / COLOR^4^73
- +51 ;;^UTILITY(U,$J,358.4,664,0)
- +52 ;;=IMAGING / PHOTOS^2^73
- +53 ;;^UTILITY(U,$J,358.4,665,0)
- +54 ;;=TEST - GLAUCOMA^3^73
- +55 ;;^UTILITY(U,$J,358.4,666,0)
- +56 ;;=TEST - OTHER^5^73
- +57 ;;^UTILITY(U,$J,358.4,667,0)
- +58 ;;=REFRACT / GLASSES / CL^1^73
- +59 ;;^UTILITY(U,$J,358.4,668,0)
- +60 ;;=EEF Version 2020 February^6^73
- +61 ;;^UTILITY(U,$J,358.4,669,0)
- +62 ;;=LOW VISION / BLINDNESS^21^74
- +63 ;;^UTILITY(U,$J,358.4,670,0)
- +64 ;;=RETINA - VASCULAR^12^74
- +65 ;;^UTILITY(U,$J,358.4,671,0)
- +66 ;;=EYELIDS / LASHES^2^74
- +67 ;;^UTILITY(U,$J,358.4,672,0)
- +68 ;;=NEURO / STRABISMUS^18^74
- +69 ;;^UTILITY(U,$J,358.4,673,0)
- +70 ;;=ORBIT - PLASTICS^20^74
- +71 ;;^UTILITY(U,$J,358.4,674,0)
- +72 ;;=VITREOUS^17^74
- +73 ;;^UTILITY(U,$J,358.4,675,0)
- +74 ;;=ORBIT - TRAUMA^19^74
- +75 ;;^UTILITY(U,$J,358.4,676,0)
- +76 ;;=LACRIMAL / NLD / NEOPLASMS^3^74
- +77 ;;^UTILITY(U,$J,358.4,677,0)
- +78 ;;=MOST FREQUENT^1^74
- +79 ;;^UTILITY(U,$J,358.4,678,0)
- +80 ;;=CONJUNCTIVA / SCLERA^4^74
- +81 ;;^UTILITY(U,$J,358.4,679,0)
- +82 ;;=CORNEA / ULCER^5^74
- +83 ;;^UTILITY(U,$J,358.4,680,0)
- +84 ;;=LENS / CATARACT / POSTOP^6^74
- +85 ;;^UTILITY(U,$J,358.4,681,0)
- +86 ;;=IRIS / UVEITIS^7^74
- +87 ;;^UTILITY(U,$J,358.4,682,0)
- +88 ;;=GLAUCOMA - OPEN ANGLE^8^74
- +89 ;;^UTILITY(U,$J,358.4,683,0)
- +90 ;;=GLAUCOMA - CLOSED ANGLE^9^74
- +91 ;;^UTILITY(U,$J,358.4,684,0)
- +92 ;;=GLAUCOMA - SECONDARY^10^74
- +93 ;;^UTILITY(U,$J,358.4,685,0)
- +94 ;;=RETINA - CHOROID / TUMORS / INFLAM^14^74
- +95 ;;^UTILITY(U,$J,358.4,686,0)
- +96 ;;=RETINA - TEAR / PERIPH / DEGENERATION^15^74
- +97 ;;^UTILITY(U,$J,358.4,687,0)
- +98 ;;=RETINA - MACULA^11^74
- +99 ;;^UTILITY(U,$J,358.4,688,0)
- +100 ;;=SUICIDE IDEATIONS/ATTEMPTS^23^74
- +101 ;;^UTILITY(U,$J,358.4,689,0)
- +102 ;;=PMH / OTHER^22^74
- +103 ;;^UTILITY(U,$J,358.4,690,0)
- +104 ;;=RETINA - VEGF INJECT DX CODES^16^74
- +105 ;;^UTILITY(U,$J,358.4,691,0)
- +106 ;;=RETINA - DIABETIC RETINOPATHY^13^74
- +107 ;;^UTILITY(U,$J,358.4,692,0)
- +108 ;;=NEW PATIENT^3^75
- +109 ;;^UTILITY(U,$J,358.4,693,0)
- +110 ;;=ESTABLISHED PATIENT^2^75
- +111 ;;^UTILITY(U,$J,358.4,694,0)
- +112 ;;=CONSULTS - OUTPT^4^75
- +113 ;;^UTILITY(U,$J,358.4,695,0)
- +114 ;;=EYE CODES^1^75
- +115 ;;^UTILITY(U,$J,358.4,696,0)
- +116 ;;=CONSULTS - INPT^5^75